We are live on ! Find out more
EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares

Delisted

EBAC was delisted on the 2nd of March, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
GCL
1
Glazer Capital LLC
New York
$6.93M +$5.12M +523,267 +283%
Millennium Management
2
Millennium Management
New York
$5.84M -$25K -2,555 -0.4%
PC
3
Periscope Capital
Ontario, Canada
$4.96M
Macquarie Group
4
Macquarie Group
Australia
$4.93M
LA
5
Linden Advisors
New York
$4.87M
Marshall Wace
6
Marshall Wace
United Kingdom
$4.27M
SC
7
Sculptor Capital
New York
$3.46M -$95K -9,711 -3%
SCM
8
Suvretta Capital Management
New York
$2.94M
PMAM
9
Picton Mahoney Asset Management
Ontario, Canada
$2.69M
WP
10
Woodline Partners
California
$2.69M
Bank of America
11
Bank of America
North Carolina
$2.54M
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$2.52M
MI
13
MMCAP International
Cayman Islands
$2.45M
RCM
14
Radcliffe Capital Management
Pennsylvania
$2.09M
AA
15
AQR Arbitrage
Connecticut
$1.96M +$979K +100,000 +100%
KL
16
KIM LLC
Kansas
$1.96M +$1.96M +200,000 New
Alyeska Investment Group
17
Alyeska Investment Group
Illinois
$1.47M
GCM
18
Ghisallo Capital Management
Massachusetts
$1.22M
MCM
19
Moore Capital Management
New York
$1.22M
FTCM
20
Fir Tree Capital Management
New York
$1.04M -$428K -43,700 -29%
State of Wisconsin Investment Board
21
State of Wisconsin Investment Board
Wisconsin
$987K
TCM
22
Tenor Capital Management
New York
$979K
DCM
23
Dupont Capital Management
Delaware
$978K
Hudson Bay Capital Management
24
Hudson Bay Capital Management
Connecticut
$978K
MF
25
Magnetar Financial
Illinois
$968K +$867K +88,596 +857%